FDA Import Refusal AEK-8102465-3/51/1 — CIPLA LTD
The FDA refused shipment AEK-8102465-3/51/1 from CIPLA LTD (India) on Jan 22, 2025. The refused product falls under Drugs and Biologics — NORFLOXACIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jan 22, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61GDA84 NORFLOXACIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC)
- Charges
- 118,75